Prevention of vasospasm after subarachnoid hemorrhage in dogs by continuous intravenous infusion of PD156707

Neurologia Medico-Chirurgica

Volumn 38, Issue SUPPL., 1998, Pages 138-145

  Macdonald, R Loch ^a   Johns, Lydia ^a   Lin, George ^a   Marton, Linda S ^a   Hallak, Hussein ^b   Marcoux, Frank ^b   Kowalczuk, Andrew ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b PFIZER INC   (United States)

Author keywords

Cerebral vasospasm; Dog; Endothelin; Subarachnoid hemorrhage

Indexed keywords

4 (4 METHOXYPHENYL) 2 (3,4 METHYLENEDIOXYPHENYL) 4 OXO 3 (3,4,5 TRIMETHOXYBENZYL) 2 BUTENOIC ACID; DRUG VEHICLE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR ANTAGONIST; LYSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY DIAMETER; BASILAR ARTERY; BRAIN ANGIOGRAPHY; BRAIN VASOSPASM; CONFERENCE PAPER; CONTINUOUS INFUSION; CONTROLLED STUDY; DOG; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; SUBARACHNOID HEMORRHAGE;

EID: 0031741091     PISSN: 03872572     EISSN: None     Source Type: Journal    
DOI: 10.2176/nmc.38.suppl_138     Document Type: Conference Paper

References (36)

1. Clozel M, Breu V, Burri K, Cassal JM, Fischli W, Gray GA, Hirth G, Löffler BM, Müller M, Neidhart W, Ramuz H: Pathophysiological role of endothelin revealed by the first orally active endothelin receptor antagonist. Nature 365: 759-761, 1993
2. Clozel M, Watanabe H: BQ-123, a peptidic endothelin ETA receptor antagonist, prevents the early cerebral vasospasm following subarachnoid hemorrhage after intracisternal but not intravenous injection. Life Sci 52: 825-834, 1993
3. A-receptor antagonist BQ-123 and phosphoramidon on cerebral vasospasm. J Cardiovasc Pharmacol 22 (Suppl 8): S332-S335, 1993
4. Ehrenreich H, Lange M, Near KA, Anneser F, Schoeller LA, Schmid R, Winkler PA, Kehrl JH, Schmiedek P, Goebel FD: Long term monitoring of immunoreactive endothelin-1 and endothelin-3 in ventricular cerebrospinal fluid, plasma, and 24-h urine of patients with subarachnoid hemorrhage. Res Exp Med (Berl) 192: 257-268, 1992
5. Foley PL, Caner HH, Kassell NF, Lee KS: Reversal of subarachnoid hemorrhage-induced vasoconstriction with an endothelin receptor antagonist. Neurosurgery 34: 108-113, 1994
6. Fujimori A, Yanagisawa M, Saito A, Goto K, Masaki T, Mima T, Takakura K, Shigeno T: Endothelin in plasma and cerebrospinal fluid of patients with subarachnoid hemorrhage. Lancet 336: 633, 1991
7. Gaetani P, Rodriguez y Baena R, Grignani G, Spanu G, Pacchiarini L, Paoletti P: Endothelin and aneurysmal subarachnoid haemorrhage: a study of subarachnoid cisternal cerebrospinal fluid. J Neurol Neurosurg Psychiatry 57: 66-72, 1994
8. Hamann G, Isenberg E, Strittmatter M, Schimrigk K: Absence of elevation of big endothelin in subarachnoid hemorrhage. Stroke 24: 383-386, 1993
9. Hino A, Tokuyama Y, Kobayashi M, Yano M, Weir B, Takeda J, Bell GI, Macdonald RL: Increased expression of endothelin B receptor mRNA following subarachnoid hemorrhage in monkeys. J Cereb Blood Flow Metab 16: 688-697, 1996
10. Hino A, Weir B, Macdonald RL, Thisted R, Kim CJ, Johns L: Prospective, randomized, double-blind trial of BQ-123 and bosentan for prevention of vasospasm following subarachnoid hemorrhage in monkeys. J Neurosurg 83: 503-509, 1995
11. Hirose H, Ide K, Sasaki T, Takahashi R, Kobayashi M, Ikemoto F, Yano M, Nishikibe M: The role of endothelin and nitric oxide in modulation of normal and spastic cerebral vascular tone in the dog. Eur J Pharmacol 227: 77-87, 1995
12. Ide K, Ito S, Sasaki T, Yano M, Kirino T: Effects of ETA receptor antagonist on normal and spastic canine basilar arteries, in Findlay JM (ed): Cerebral Vasospasm. Amsterdam, Elsevier, 1993, pp 213-216
13. Ikegawa R, Matsumura Y, Tsukahara Y, Takaoka M, Morimoto S: Phosphoramidon, a metalloproteinase inhibitor, suppresses the secretion of endothelin-1 from cultured endothelial cells by inhibiting big endothelin-1 converting enzyme. Biochem Biophys Res Commun 171: 669-675, 1990
14. A receptor mRNA expression in a canine subarachnoid hemorrhage model. J Neurosurg 81: 759-764, 1994
15. A receptor antagonist, BQ-485, and its preventive effect on experimental cerebral vasospasm in dogs. Biochem Biophys Res Commun 195: 969-975, 1993
16. Kim CJ, Bassiouny M, Macdonald RL, Weir B, Johns LM: Effect of BQ-123 and tissue plasminogen activator on vasospasm after subarachnoid hemorrhage in monkeys. Stroke 27: 1629-1633, 1996
17. Kraus GE, Bucholz RD, Yoon KW, Kneupfer MM, Smith KR Jr: Cerebrospinal fluid endothelin-1 and endothelin-3 levels in normal and neurosurgical patients: a clinical study and literature review. Surg Neurol 35: 20-29, 1991
18. Lüscher TF, Boulanger CM, Dohi Y, Yang Z: Endothelium-derived contracting factors. Hypertension 19: 117-130, 1992
19. Macdonald RL, Zhang J, Sima B, Johns L: Papaverine-sensitive vasospasm and arterial contractility and compliance following subarachnoid hemorrhage in dogs. Neurosurgery 37: 962-968, 1995
20. Masaoka H, Suzuki R, Hirata Y, Emori T, Marumo F, Hirakawa K: Raised plasma endothelin in aneurysmal subarachnoid hemorrhage. Lancet 2:1402-1403, 1989
21. Matsumura Y, Ikegawa R, Suzuki Y, Masanori T, Uchida T, Kido H, Shinyama H, Hayashi K, Watanabe M, Morimoto S: Phosphoramidon prevents cerebral vasospasm following subarachnoid hemorrhage in dogs: the relationship to endothelin-1 levels in the cerebrospinal fluid. Life Sci 49: 841-848, 1991
22. A receptor antagonist, FR139317, ameliorates cerebral vasospasm in dogs. Life Sci 52: 1869-1874, 1993
23. Pluta RM, Boock RJ, Afshar JK, Clouse K, Bacic M, Ehrenreich H, Oldfield EH: The source and cause of endothelin-1 release to cerebrospinal fluid after subarachnoid hemorrhage. J Neurosurg 87: 287-293, 1997
24. A receptor antagonist. J Pharmacol Exp Ther 273: 1410-1417, 1995
25. Rossi DT, Hallak H, Bradford L: Liquid chromatographic assay for a butenolide endothelin antagonist (PD 156707) in plasma. J Chromatogr B Biomed Appl 677: 299-304, 1996
26. Roux SP, Loffler BM, Gray GA, Sprecher U, Clozel M, Clozel JP: The role of endothelin in experimental cerebral vasospasm. Neurosurgery 37: 78-86, 1995
27. Seifert V, Loffler BM, Zimmermann M, Roux S, Stolke D: Endothelin concentrations in patients with aneurysmal subarachnoid hemorrhage. Correlation with cerebral vasospasm, delayed ischemic neurological deficits, and volume of hematoma. J Neurosurg 82: 55-62, 1995
28. Shigeno T, Clozel M, Sakai S, Saito A, Goto K: The effect of bosentan, a new potent endothelin receptor antagonist, on the pathogenesis of cerebral vasospasm. Neurosurgery 37: 87-91, 1995
29. Shigeno Y, Mima T, Yanagisawa M, Saito A, Fujumori A, Shiba R, Goto K, Kimura S, Yamashita K, Yanasaki Y, Masaki T, Takakura K: Possible role of endothelin in the pathogenesis of cerebral vasospasm. J Cardiovasc Pharmacol 17 (Suppl 7): S480-S483, 1991
30. Suzuki H, Sato S, Suzuki Y, Takekoshi K, Ishihara N, Shimoda S: Increased endothelin concentration in CSF from patients with subarachnoid hemorrhage. Acta Neurol Scand 81: 553-554, 1990
31. Suzuki R, Masaoka H, Hirata Y, Marumo F, Isotani E, Hirakawa K: The role of endothelin-1 in the origin of cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 77: 96-100, 1992
32. Willette RN, Zhang H, Mitchell MP, Sauermelch CF, Ohlstein EH, Sulpizio AC: Nonpeptide endothelin antagonist. Cerebrovascular characterization and effects on delayed cerebral vasospasm. Stroke 25: 2450-2456, 1994
33. Yamaura I, Tani E, Maeda Y, Minami N, Shindo H: Endothelin-1 of canine basilar artery in vasospasm. J Neurosurg 76: 99-105, 1992
34. Zimmerman M, Seifert V, Löffler BM, Stolke D, Stenzel W: Prevention of cerebral vasospasm after experimental subarachnoid hemorrhage by RO 47-0203, a newly developed orally active endothelin receptor antagonist. Neurosurgery 38: 115-120, 1996
35. B receptors in subarachnoid hemorrhage-induced cerebral vasospasm. Eur J Pharmacol 259: R1-R2, 1994
36. Zuccarello M, Soattin GB, Lewis AI, Breu V, Hallak H, Rapoport RM: Prevention of subarachnoid hemorrhage-induced cerebral vasospasm by oral administration of endothelin receptor antagonists. J Neurosurg 84: 503-507, 1996